8ESB
| |
8ESA
| |
8ES9
| |
8ES8
| |
7Z50
| |
3I6G
| Newly identified epitope Mn2 from SARS-CoV M protein complexed withHLA-A*0201 | 分子名称: | Beta-2-microglobulin, HLA class I histocompatibility antigen, A-2 alpha chain, ... | 著者 | Liu, J. | 登録日 | 2009-07-07 | 公開日 | 2010-06-16 | 最終更新日 | 2023-11-01 | 実験手法 | X-RAY DIFFRACTION (2.201 Å) | 主引用文献 | The membrane protein of severe acute respiratory syndrome coronavirus acts as a dominant immunogen revealed by a clustering region of novel functionally and structurally defined cytotoxic T-lymphocyte epitopes. J.INFECT.DIS., 202, 2010
|
|
3HLA
| |
8EK5
| Engineered scFv 10LH bound to PHOX2B/HLA-A24:02 | 分子名称: | 10LH single chain fragment variable (scFv), Beta-2-microglobulin, GLYCEROL, ... | 著者 | Garfinkle, S.E, Florio, T.J, Sgourakis, N.G. | 登録日 | 2022-09-20 | 公開日 | 2023-12-06 | 最終更新日 | 2023-12-13 | 実験手法 | X-RAY DIFFRACTION (2.11 Å) | 主引用文献 | Structural principles of peptide-centric chimeric antigen receptor recognition guide therapeutic expansion. Sci Immunol, 8, 2023
|
|
7YX9
| |
7YXB
| MHC-II dynamics are maintained in HLA-DR allotypes to ensure catalyzed peptide exchange | 分子名称: | 1,2-ETHANEDIOL, CITRATE ANION, CLIP peptide, ... | 著者 | Roske, Y, Abualrous, E.T, Freund, C. | 登録日 | 2022-02-15 | 公開日 | 2023-02-22 | 最終更新日 | 2024-02-07 | 実験手法 | X-RAY DIFFRACTION (2.095 Å) | 主引用文献 | MHC-II dynamics are maintained in HLA-DR allotypes to ensure catalyzed peptide exchange. Nat.Chem.Biol., 19, 2023
|
|
8EMG
| |
8EMF
| |
8EMI
| |
8EMJ
| |
8ENH
| |
8EMK
| |
8EN8
| |
7Z0Q
| MHC-II dynamics are maintained in HLA-DR allotypes to ensure catalyzed peptide exchange | 分子名称: | 1,2-ETHANEDIOL, CLIP peptide, HLA class II histocompatibility antigen, ... | 著者 | Roske, Y, Abualrous, E.T, Freund, C. | 登録日 | 2022-02-23 | 公開日 | 2023-03-08 | 最終更新日 | 2024-02-07 | 実験手法 | X-RAY DIFFRACTION (2.1 Å) | 主引用文献 | MHC-II dynamics are maintained in HLA-DR allotypes to ensure catalyzed peptide exchange. Nat.Chem.Biol., 19, 2023
|
|
8EO8
| |
8F7M
| |
8FHL
| |
8FHU
| |
3IU3
| Crystal structure of the Fab fragment of therapeutic antibody Basiliximab in complex with IL-2Ra (CD25) ectodomain | 分子名称: | Heavy chain of Fab fragment of Basiliximab, Interleukin-2 receptor alpha chain, Light chain of Fab fragment of Basiliximab, ... | 著者 | Du, J, Yang, H, Wang, J, Ding, J. | 登録日 | 2009-08-29 | 公開日 | 2010-01-26 | 最終更新日 | 2023-11-01 | 実験手法 | X-RAY DIFFRACTION (2.9 Å) | 主引用文献 | Structural basis for the blockage of IL-2 signaling by therapeutic antibody basiliximab J.Immunol., 184, 2010
|
|
7ZT2
| Structure of E8 TCR in complex with human MR1 bound to 5-OP-RU | 分子名称: | 1,2-ETHANEDIOL, 1-deoxy-1-({2,6-dioxo-5-[(E)-propylideneamino]-1,2,3,6-tetrahydropyrimidin-4-yl}amino)-D-ribitol, Beta-2-microglobulin, ... | 著者 | Karuppiah, V, Srikannathasan, V, Robinson, R.A. | 登録日 | 2022-05-09 | 公開日 | 2023-06-28 | 最終更新日 | 2024-02-07 | 実験手法 | X-RAY DIFFRACTION (2.4 Å) | 主引用文献 | Promiscuous recognition of MR1 drives self-reactive mucosal-associated invariant T cell responses. J.Exp.Med., 220, 2023
|
|
7ZT4
| |